Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%), etc.
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%), etc.
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%), etc.
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%), etc.
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Persson Magnus
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Almenoff June Sherie
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KAPLAN GILLA
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chan Mitchell
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Persson Magnus
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Almenoff June Sherie
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caissa Capital Management Ltd.(0%),Cambyz Golestaneh(0%)
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARMISTICE CAPITAL, LLC
Avalo Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Caissa Capital Management ltd.
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Caissa Capital Management ltd.
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Caissa Capital Management ltd.
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sullivan Christopher Ryan
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer NEIL GARRY ARTHUR
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Caissa Capital Management ltd.
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Caissa Capital Management ltd.
No Data